Grant: $272,345 - National Institutes of Health - Apr. 28, 2009
No votes have been cast for this award yet
Award Description: This research project is relevant to public health because it will result in the development of a novel therapeutic that can specifically target HER2+ breast cancer. This targeted therapy should be an improvement over conventional treatment methods because normal cells should not be affected. As HER2+ breast cancer does not respond well to conventional therapies, this alternative therapy could provide a significant contribution to breast cancer treatment, and could be modified to target therapy to other types of cancer.
Project Description: Protein-DNA Drug Carriers for Tumor Targeting
Jobs Summary: Two Research Associate (Technician) positions and a postdoctoral position at 30% effort each are being covered by this funding . The Technician positions entail recombinant molecular biology techniques for protein production, purification, and analysis; cell culturing and maintenance; limited viral work; and basic in vitro and in vivo experiments under the direction and supervision of the PI. The Postdoctoral position will entail more advanced and more independent experimentation in cell culture and in vivo of tumor targeting and treatment, and involves more advanced methods of experimental design and analysis. The postdoctoral position will be filled beginning October 1. (Total jobs reported: 0)
Project Status: Less Than 50% Completed
This award's data was last updated on Apr. 28, 2009. Help expand these official descriptions using the wiki below.